Related Experiment Videos
[Clinical study of the diuretic preparation moduretic]
Insights
Moduretic effectively treats circulatory insufficiency by increasing sodium excretion and retaining potassium. While it may increase thrombogenesis risk in early stages, it
Area of Science:
- Pharmacology
- Cardiology
- Nephrology
Context:
- Circulatory insufficiency presents a significant clinical challenge, necessitating effective diuretic and antihypertensive therapies.
- Understanding the impact of diuretics on electrolyte balance and hemocoagulation is crucial for patient safety and treatment efficacy.
Purpose:
- To evaluate the diuretic, electrolyte-modulating, hemocoagulation, and antihypertensive effects of moduretic in patients with circulatory insufficiency and hypertension.
Summary:
- Moduretic demonstrated a significant diuretic effect, increasing sodium excretion while retaining potassium without causing hyperkalemia.
- The study indicated a potential risk of thrombogenesis in patients with circulatory insufficiency of degree I, but identified moduretic as a preferred agent for degrees IIA, IIB, and III.
- In hypertensive patients (stages I-IIA), moduretic effectively reduced both systolic and diastolic arterial pressure.
Impact:
- Moduretic offers a valuable therapeutic option for managing circulatory insufficiency across various stages.
- The findings highlight the importance of monitoring hemocoagulation in specific patient groups when initiating moduretic therapy.
- Moduretic contributes to blood pressure management in hypertensive patients, potentially improving cardiovascular outcomes.
Abstract:
In 75 patients with circulatory insufficiency of various degree the diuretic effect of moduretic was studied. In 25 of them besides the potassium and sodium metabolism and in 33 others, with a background of chronic ischemic disease of the heart and hypertensive disease, the state of the hemocoagulation system was investigated in the moduretic medication. In 24 patients with hypertensive disease of the I--IIA stage subject to study was the effect of moduretic on the arterial pressure, with this drug administered by mouth in doses of 3 to 1/2 tablet a day. The drug proved to have a marked duretic effect in patients with different degree of circulatory insufficiency. It increases sodium excretion with urine and retains potassium in the organism, without causing hyperkaliemia. In patients with circulatory insufficiency of the I degree the drug can provoke thrombogenesis and in cases of the IIA, IIB and III degree may be considered a drug of choice. Moduretic brings down the systolic and diastolic pressure in patients with hypertensive disease of the I and II stages.